Cargando…
EYA2 suppresses the progression of hepatocellular carcinoma via SOCS3-mediated blockade of JAK/STAT signaling
BACKGROUND: Somatic mutations are involved in hepatocellular carcinoma (HCC) progression, but the genetic mechanism associated to hepatocarcinogenesis remains poorly understood. We report that Eyes absent homolog 2 (EYA2) suppresses the HCC progression, while EYA2(A510E) mutation identified by exome...
Autores principales: | Liu, Ze-Kun, Li, Can, Zhang, Ren-Yu, Wei, Ding, Shang, Yu-Kui, Yong, Yu-Le, Kong, Ling-Min, Zheng, Nai-Shan, Liu, Ke, Lu, Meng, Liu, Man, Hu, Cai-Xia, Yang, Xiao-Zhen, Chen, Zhi-Nan, Bian, Huijie |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8157759/ https://www.ncbi.nlm.nih.gov/pubmed/34044846 http://dx.doi.org/10.1186/s12943-021-01377-9 |
Ejemplares similares
-
SPTBN1 suppresses the progression of epithelial ovarian cancer via SOCS3-mediated blockade of the JAK/STAT3 signaling pathway
por: Chen, Mo, et al.
Publicado: (2020) -
The molecular basis of JAK/STAT inhibition by SOCS1
por: Liau, Nicholas P. D., et al.
Publicado: (2018) -
SIX1 Activates STAT3 Signaling to Promote the Proliferation of Thyroid Carcinoma via EYA1
por: Kong, Deguang, et al.
Publicado: (2019) -
Shikonin attenuates rheumatoid arthritis by targeting SOCS1/JAK/STAT signaling pathway of fibroblast like synoviocytes
por: He, Lianhua, et al.
Publicado: (2021) -
Systems analysis of key genes and pathways in the progression of hepatocellular carcinoma
por: Shang, Yu-Kui, et al.
Publicado: (2018)